Cell Cycle-Blocking Drugs Can Shrink Tumors by Enlisting Immune System in Attack on Cancer, Study Finds

• Study explains why CDK4/6 inhibitors can shrink tumor in some advanced breast cancers • CDK4/6 inhibitors trigger the immune system to attack tumor cells • CDK4/6 inhibitors can also enhance anti-cancer effect of immunotherapy agents
15-Aug-2017 1:00 PM EDT Add to Favorites

Dana-Farber/Brigham and Women's Cancer Center the Best in the Region for Cancer Care for 17th Year

Dana-Farber /Brigham and Women's Cancer Center is ranked no. 4 in cancer by U.S. News and World Report.
8-Aug-2017 9:10 AM EDT Add to Favorites

Dana-Farber Debuts New Name, State-of-the-Art Facility for Integrative Therapies

The Dana-Farber Cancer Institute is pleased to announce the opening of the new Leonard P. Zakim Center for Integrative Therapies and Healthy Living, underscoring Dana-Farber’s commitment to providing cutting-edge patient therapies and support for...
7-Aug-2017 10:05 AM EDT Add to Favorites

Four Dana-Farber Researchers Awarded Prestigious “Outstanding Investigator Awards” by National Cancer Institute

The National Cancer Institute (NCI) has awarded four Dana-Farber Cancer Institute researchers with Outstanding Investigator Awards (OIA) for ongoing progressive research within their respective areas of study.
2-Jun-2017 10:05 AM EDT Add to Favorites

Dana-Farber Cancer Institute Names Lesley Solomon SVP, Chief Innovation Officer

Dana-Farber Cancer Institute has named Lesley Solomon to the newly-created position of senior vice president for innovation and chief innovation officer. Solomon has been serving as executive director of the Brigham Innovation Hub at Brigham and...
31-May-2017 11:05 AM EDT Add to Favorites

Backed by Dana-Farber Research, FDA Approves New AML Drug

A targeted drug whose clinical testing was led by Richard Stone, MD, of Dana-Farber Cancer Institute, has become the first new treatment for newly diagnosed acute myeloid leukemia (AML) in more than 25 years.
5-May-2017 12:05 PM EDT Add to Favorites

Dana-Farber/Harvard Cancer Center Leader Wins 'Reducing Health Disparities Award' From Mass Medical Society

Karen Burns White, Deputy Associate Director of Dana-Farber/Harvard Cancer Center’s (DF/HCC) Initiative to Eliminate Cancer Disparities (IECD) since 2001, has been honored by the Massachusetts Medical Society as the 2017 recipient of the...
18-Apr-2017 3:05 PM EDT Add to Favorites

Dana-Farber Cancer Institute Named Top 100 Great Hospital in America

Dana-Farber Cancer Institute has been recognized as a “Top 100 Great Hospital in America” by Becker's Hospital Review.
18-Apr-2017 3:05 PM EDT Add to Favorites